Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
All through October, CURE highlighted analysis developments and evolving remedy methods that proceed to form most cancers care. From minimally invasive surgical...
Amongst sufferers with beforehand handled non-squamous non-small cell lung most cancers with out actionable genetic mutations, new information has been launched from...
Specialised, multidisciplinary care at high-volume sarcoma facilities assist younger adults with sarcoma obtain the best and coordinated remedy, though entry to those...
